Opal Capital’s Merck MRK Stock Holding History

Opal Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.43M	Buy	11,928 +9,098	+321%	+$1.05M	0.25%	99
2025 Q4	$327K	Buy	+2,830	New	+$266K	0.08%	126

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Opal Capital's MRK Position: Q1 2026 in Review

Opal Capital increased its Merck (MRK) stake by 321% in Q1 2026, buying an estimated $1.05M and bringing the position to 11,928 shares worth $1.43M. The position accounts for 0.25% of the portfolio, ranked #99.

Opal Capital first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Opal Capital held 11,928 shares of Merck worth $1.43M as of Q1 2026.
Opal Capital bought 9,098 Merck shares in Q1 2026, an estimated $1.05M.
Merck made up 0.25% of Opal Capital's portfolio in Q1 2026, its #99 holding.
Opal Capital first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Opal Capital's 13F filing for Q1 2026, filed 18 May 2026.